20n Bio Appoints Linghang Zhuang, Ph.D., as President, to lead the discovery of cyclic peptide drugs

-20n Bio, a biotechnology company specializing in peptide drug discovery, announced the appointment of Linghang Zhuang, PhD, as President, effective February 1